Eli Lilly and Co. Deal History & Licensing Activity

About Eli Lilly and Co. Licensing & Deal Activity

Eli Lilly and Co. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 43 deals over the past three years, Eli Lilly and Co. ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Eli Lilly and Co. include Mega Deals (24 deals and trials), Metabolic (18 deals and trials), Cardiovascular (9 deals and trials), and Autoimmune (7 deals and trials). In terms of modality, Eli Lilly and Co. has shown particular interest in small molecules, other, antibodies.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Eli Lilly and Co. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Eli Lilly and Co.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.